SCOPUS 정보 검색 플랫폼

Volumn 107, Issue 4, 2011, Pages 644-645

The novel Kv1.5 channel blocker vernakalant for successful treatment of new-onset atrial fibrillation in a critically ill abdominal surgical patient

(2) Friederich, P a Pfizenmayer, H a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; C REACTIVE PROTEIN; DIGOXIN; DOBUTAMINE; MAGNESIUM; NORADRENALIN; VERNAKALANT;

AGED; CASE REPORT; CONTINUOUS INFUSION; CRITICAL ILLNESS; DRUG WITHDRAWAL; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; ILEUS; LAPAROTOMY; LETTER; LEUKOCYTOSIS; MALE; PRIORITY JOURNAL; SEPSIS; SINUS RHYTHM; TREATMENT RESPONSE;

EID: 80052644930 PISSN: 00070912 EISSN: 14716771 Source Type: Journal
DOI: 10.1093/bja/aer278 Document Type: Letter

Times cited : (7)

References (6)

1
- 1542611654
- Incidence and risk factors of atrial fibrillation in a surgical intensive care unit
- DOI 10.1097/01.CCM.0000114579.56430.E0
- Seguin P, Signouret T, Laviolle B, Branger B, Mallédant Y. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med 2004; 32: 722-6 (Pubitemid 38344141)
- (2004) Critical Care Medicine , vol.32 , Issue.3 , pp. 722-726
- Seguin, P.¹ Signouret, T.² Laviolle, B.³ Branger, B.⁴ Malledant, Y.⁵

2
- 0031839533
- The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality
- Brathwaite D, Weissman C. The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest 1998; 114: 462-8 (Pubitemid 28387524)
- (1998) Chest , vol.114 , Issue.2 , pp. 462-468
- Brathwaite, D.¹ Weissman, C.²

3
- 77950297293
- New antiarrhythmic drugs for treatment of atrial fibrillation
- Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 2010; 375: 1212-23
- (2010) Lancet , vol.375 , pp. 1212-1223
- Dobrev, D.¹ Nattel, S.²

4
- 41149179489
- Vernakalant hydrochloride for rapid conversion of atrial fibrillation: A phase 3, randomized, placebo-controlled trial
- DOI 10.1161/CIRCULATIONAHA.107.723866, PII 0000301720080325000006
- Roy D, Pratt CM, Torp-Pedersen C, et al. Atrial Arrhythmia Conversion Trial Investigators. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebocontrolled trial. Circulation 2008; 117: 1518-25 (Pubitemid 351440640)
- (2008) Circulation , vol.117 , Issue.12 , pp. 1518-1525
- Roy, D.¹ Pratt, C.M.² Torp-Pedersen, C.³ Wyse, D.G.⁴ Toft, E.⁵ Juul-Moller, S.⁶ Nielsen, T.⁷ Rasmussen, S.L.⁸ Stiell, I.G.⁹ Coutu, B.¹⁰ Ip, J.H.¹¹ Pritchett, E.L.C.¹² Camm, A.J.¹³

5
- 73949106527
- Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: A randomized, double-blind, placebo-controlled trial
- Atrial Arrhythmia Conversion Trial Investigators
- Kowey PR, Dorian P, Mitchell LB, et al. Atrial Arrhythmia Conversion Trial Investigators. Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009; 2: 652-9
- (2009) Circ Arrhythm Electrophysiol , vol.2 , pp. 652-659
- Kowey, P.R.¹ Dorian, P.² Mitchell, L.B.³

6
- 78651329673
- A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation
- AVRO Investigators
- Camm AJ, Capucci A, Hohnloser SH, et al. AVRO Investigators. A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol 2011; 57: 313-21
- (2011) J Am Coll Cardiol , vol.57 , pp. 313-321
- Camm, A.J.¹ Capucci, A.² Hohnloser, S.H.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.